
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Shares | 95.940 | 95.940 | 0.000 |
Bonds | 0.180 | 0.180 | 0.000 |
Convertible | 0.160 | 0.160 | 0.000 |
Preferred | 3.680 | 3.680 | 0.000 |
Other | 0.070 | 0.170 | 0.100 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 20.853 | 20.853 |
Price to Book | 4.300 | 4.300 |
Price to Sales | 2.078 | 2.078 |
Price to Cash Flow | 18.525 | 18.525 |
Dividend Yield | 0.721 | 0.721 |
5 Years Earnings Growth | 10.431 | 10.431 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.930 | 99.930 |
Financial Services | 0.070 | 0.070 |
Number of long holdings: 270
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 10.27 | 737.67 | +2.09% | |
UnitedHealth | US91324P1021 | 6.21 | 301.91 | +1.25% | |
Intuitive Surgical | US46120E6023 | 5.88 | 552.34 | -0.61% | |
Thermo Fisher Scientific | US8835561023 | 4.61 | 402.82 | -0.23% | |
Stryker | US8636671013 | 4.23 | 382.64 | +0.08% | |
Danaher | US2358511028 | 3.77 | 189.90 | -0.30% | |
argenx ADR | US04016X1019 | 3.72 | 573.26 | -1.32% | |
Merck&Co | US58933Y1055 | 2.55 | 76.84 | +0.58% | |
Boston Scientific | US1011371077 | 2.54 | 105.26 | +0.73% | |
Vertex | US92532F1003 | 2.42 | 442.05 | -1.13% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
TD Dividend Growth Fund Premium F | 11.34B | -1.27 | 7.21 | 8.21 | ||
TD Dividend Growth Fund Premium s | 11.34B | -1.70 | 5.98 | 6.99 | ||
TD Dividend Growth Fund D-Series | 11.34B | -1.29 | 7.10 | - | ||
TD Dividend Growth I | 11.34B | -1.68 | 5.92 | 6.93 | ||
TD Dividend Growth F | 11.34B | -1.31 | 7.15 | 8.15 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review